Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harmony Health One Inc. was a Canadian pharmaceutical and medical cannabis company that operated as a subsidiary of Franchise Global Health Inc. (FGH). The company specialized in the development and distribution of pharmaceutical-grade cannabis products and held intellectual property licenses for various cannabis-based therapies. In December 2022, it was acquired by Flora Growth Corp. (now ZeroStack Corp.) as part of a larger acquisition of the Franchise Global Health group. Harmony Health One focused on international distribution and brand development within the medical cannabis sector until it filed for voluntary bankruptcy in March 2025. Its operations were closely integrated with other subsidiaries like Phatebo GmbH to serve the European medical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harmony Health One.